Cargando…
Indirubin suppresses ovarian cancer cell viabilities through the STAT3 signaling pathway
BACKGROUND: Indirubin is the active component of Danggui Longhui Wan, a traditional Chinese medicine formulation. Due to its anti-inflammation and anti-tumor effects, indirubin has been widely used for the treatment of inflammation, cancer, and other chronic disease. Herein, we aimed to investigate...
Autores principales: | Chen, Lihong, Wang, Jinhua, Wu, Jianbo, Zheng, Qiaomei, Hu, Jifen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6174913/ https://www.ncbi.nlm.nih.gov/pubmed/30323565 http://dx.doi.org/10.2147/DDDT.S174613 |
Ejemplares similares
-
An Indirubin Derivative, Indirubin-3′-Monoxime Suppresses Oral Cancer Tumorigenesis through the Downregulation of Survivin
por: Lo, Wan-Yu, et al.
Publicado: (2013) -
Indirubin and Indirubin Derivatives for Counteracting Proliferative Diseases
por: Blažević, Tina, et al.
Publicado: (2015) -
Effects of indirubin and isatin on cell viability, mutagenicity, genotoxicity and BAX/ERCC1 gene expression
por: Fogaça, Manoela Viar, et al.
Publicado: (2017) -
MS: Wip1 suppresses angiogenesis through the STAT3-VEGF signalling pathway in serous ovarian cancer
por: Yin, Sheng, et al.
Publicado: (2022) -
Correction: Wip1 suppresses angiogenesis through the STAT3-VEGF signalling pathway in serous ovarian cancer
por: Yin, Sheng, et al.
Publicado: (2022)